{"id":"ketorolac-eye-drops","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Eye irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that blocks the production of prostaglandins, which are hormone-like substances that cause pain and inflammation in the eye. By inhibiting prostaglandin synthesis, ketorolac eye drops reduce inflammation and pain in the eye, making it a useful treatment for conditions such as ocular pain and inflammation.","oneSentence":"Ketorolac eye drops work by reducing inflammation and pain in the eye by inhibiting prostaglandin synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:17:52.171Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ocular pain and inflammation"}]},"trialDetails":[{"nctId":"NCT04505566","phase":"PHASE1","title":"INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stephen J. Kim, MD","startDate":"2020-11-09","conditions":"Diabetic Retinopathy","enrollment":164},{"nctId":"NCT05157113","phase":"PHASE4","title":"Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-05-31","conditions":"Cataract, Surgery, Compliance, Patient","enrollment":70},{"nctId":"NCT06681688","phase":"PHASE1, PHASE2","title":"Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC","status":"RECRUITING","sponsor":"Inder Paul Singh, M.D.","startDate":"2024-07-10","conditions":"Cataract","enrollment":94},{"nctId":"NCT05158699","phase":"PHASE3","title":"Effectiveness of Periocular Drug Injection in CATaract Surgery","status":"TERMINATED","sponsor":"Luigi Rondas","startDate":"2021-10-13","conditions":"Macular Edema, Cystoid Macular Edema, Retinal Disease","enrollment":628},{"nctId":"NCT06616922","phase":"PHASE2","title":"Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults","status":"COMPLETED","sponsor":"NTC srl","startDate":"2021-11-05","conditions":"Conjunctivitis, Bacterial","enrollment":252},{"nctId":"NCT01704989","phase":"PHASE4","title":"The Laser in Pseudoexfoliation (LIP) Study","status":"WITHDRAWN","sponsor":"Nova Scotia Health Authority","startDate":"2012-06","conditions":"Glaucoma","enrollment":""},{"nctId":"NCT06539637","phase":"EARLY_PHASE1","title":"Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%","status":"RECRUITING","sponsor":"DHS Consulting","startDate":"2023-09-01","conditions":"Cataract","enrollment":20},{"nctId":"NCT06498440","phase":"PHASE4","title":"Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT","status":"NOT_YET_RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2024-09-01","conditions":"Open Angle Glaucoma, Ocular Hypertension, Postoperative Inflammation","enrollment":126},{"nctId":"NCT03693183","phase":"PHASE2","title":"Efficacy Study of Ketorolac and HPMC to Treat Dry Eye","status":"WITHDRAWN","sponsor":"ORA, Inc.","startDate":"2009-03","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT04316936","phase":"PHASE4","title":"Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery","status":"COMPLETED","sponsor":"Silverstein Eye Centers","startDate":"2019-12-10","conditions":"Cataract Surgery","enrollment":15},{"nctId":"NCT00634972","phase":"PHASE4","title":"Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity","status":"TERMINATED","sponsor":"University of South Alabama","startDate":"2005-11","conditions":"Retinopathy of Prematurity, Retinal Detachment, Blindness","enrollment":83},{"nctId":"NCT02344225","phase":"PHASE2","title":"Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)","status":"COMPLETED","sponsor":"State University of New York - Downstate Medical Center","startDate":"2015-01-01","conditions":"Retinopathy of Prematurity","enrollment":14},{"nctId":"NCT04205916","phase":"PHASE4","title":"A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery","status":"RECRUITING","sponsor":"Ophthalmic Consultants of Long Island","startDate":"2019-11-04","conditions":"Patient Preference","enrollment":50},{"nctId":"NCT01871077","phase":"PHASE1","title":"Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers.","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2013-09","conditions":"Healthy","enrollment":30},{"nctId":"NCT00981435","phase":"PHASE4","title":"Steroids After Laser Trabeculoplasty for Glaucoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-09","conditions":"Glaucoma","enrollment":97},{"nctId":"NCT03851172","phase":"PHASE2","title":"Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-03-01","conditions":"Cataract, Miosis","enrollment":75},{"nctId":"NCT03551808","phase":"PHASE2","title":"Prophylactic Effect of Ketorolac Tromethamine on the Cystoid Macular Edema After Phacoemulsification in Diabetic Patients","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2017-01-01","conditions":"Cystoid Macular Edema After Phacoemulsification","enrollment":102},{"nctId":"NCT03402100","phase":"NA","title":"Eye Drops Study for Myopia Control in Schoolchildren","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2014-10-20","conditions":"Myopia, Progressive, Atropine Allergy","enrollment":150},{"nctId":"NCT01769352","phase":"PHASE2, PHASE3","title":"Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-08","conditions":"Post-surgical Cystoid Macular Edema (PSCME)","enrollment":42},{"nctId":"NCT01673191","phase":"PHASE2","title":"A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus","status":"COMPLETED","sponsor":"Retinal Consultants of Arizona","startDate":"2012-11","conditions":"Macular Edema, Diabetes Mellitus","enrollment":40},{"nctId":"NCT02752646","phase":"NA","title":"Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%","status":"COMPLETED","sponsor":"MDbackline, LLC","startDate":"2016-04","conditions":"Cataract","enrollment":200},{"nctId":"NCT01609881","phase":"PHASE1","title":"The Role of Prostaglandins in the Progression of Diabetic Retinopathy","status":"WITHDRAWN","sponsor":"Vanderbilt University","startDate":"2012-03","conditions":"Inflammation","enrollment":""},{"nctId":"NCT00405730","phase":"PHASE3","title":"Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2005-11","conditions":"Cataracts","enrollment":227},{"nctId":"NCT00330798","phase":"PHASE4","title":"A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2006-02","conditions":"Photorefractive Keratectomy","enrollment":40},{"nctId":"NCT00478036","phase":"NA","title":"Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2007-05","conditions":"Open Angle Glaucoma","enrollment":31},{"nctId":"NCT02646072","phase":"PHASE4","title":"Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2014-08","conditions":"Cystoid Macular Edema, Postoperative, Diabetes Mellitus","enrollment":80},{"nctId":"NCT01504074","phase":"","title":"Morphological and Functional Evaluation of Irvine-Gass Syndrome","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-11","conditions":"Irvine Gass Syndrome","enrollment":50},{"nctId":"NCT00485108","phase":"NA","title":"Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty","status":"COMPLETED","sponsor":"Queen's University","startDate":"2007-01","conditions":"Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma","enrollment":120},{"nctId":"NCT01799863","phase":"PHASE2, PHASE3","title":"Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis","status":"COMPLETED","sponsor":"Fundação Altino Ventura","startDate":"2012-06","conditions":"Conjunctivitis, Viral","enrollment":50},{"nctId":"NCT00900887","phase":"PHASE2","title":"Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema","status":"COMPLETED","sponsor":"Hospital Juarez de Mexico","startDate":"2008-04","conditions":"Diabetic Retinopathy, Macular Edema","enrollment":84},{"nctId":"NCT00907114","phase":"PHASE2","title":"Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy","status":"COMPLETED","sponsor":"Hospital Juarez de Mexico","startDate":"2009-06","conditions":"Proliferative Diabetic Retinopathy, Macular Edema","enrollment":44},{"nctId":"NCT02361645","phase":"PHASE3","title":"NSAIDs and PGE2 Levels in Vitrectomy Patients","status":"COMPLETED","sponsor":"Università degli Studi di Brescia","startDate":"2014-03","conditions":"Vitreous Inflammation","enrollment":70},{"nctId":"NCT01640171","phase":"NA","title":"Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival","status":"COMPLETED","sponsor":"Retina Vitreous Associates of Florida","startDate":"2012-07","conditions":"Age-related Macular Degeneration, Central Retinal Vein Occlusion, Diabetic Macular Edema","enrollment":57},{"nctId":"NCT02084576","phase":"PHASE4","title":"Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification","status":"COMPLETED","sponsor":"Hospital Oftalmologico de Brasilia","startDate":"2013-08","conditions":"Cystoid Macular Edema, Cataract","enrollment":40},{"nctId":"NCT02060604","phase":"PHASE4","title":"Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration","status":"COMPLETED","sponsor":"Università degli Studi di Brescia","startDate":"2012-12","conditions":"Wet Macular Degeneration","enrollment":60},{"nctId":"NCT00904904","phase":"PHASE4","title":"Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2008-04","conditions":"Cataract, Inflammation","enrollment":120},{"nctId":"NCT00332774","phase":"PHASE3","title":"Nevanac 3-Month Safety Study With QID Dosing","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2006-02","conditions":"Cataract","enrollment":149},{"nctId":"NCT01193231","phase":"","title":"A 6 Month Study to Evaluate the Safety, Analgesic Efficacy of ACUVAIL™ (Ketorolac Tromethamine Ophthalmic Solution) 0.45%, in Post-PRK Corneal Wound Healing","status":"COMPLETED","sponsor":"Durrie Vision","startDate":"2010-08","conditions":"Must be PRK Candidate","enrollment":10},{"nctId":"NCT01258309","phase":"PHASE3","title":"Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-12","conditions":"Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic","enrollment":129},{"nctId":"NCT00791323","phase":"PHASE4","title":"Efficacy of Ketorolac 0.4% in Prostaglandin Suppression","status":"COMPLETED","sponsor":"Allergan","startDate":"2008-11","conditions":"Inflammation","enrollment":9},{"nctId":"NCT00521456","phase":"PHASE3","title":"A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery","status":"COMPLETED","sponsor":"Allergan","startDate":"2007-10","conditions":"Cataract Extraction","enrollment":263},{"nctId":"NCT00524264","phase":"PHASE3","title":"A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery","status":"COMPLETED","sponsor":"Allergan","startDate":"2007-10","conditions":"Cataract Extraction, Pain, Inflammation","enrollment":248},{"nctId":"NCT00869219","phase":"PHASE4","title":"Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)","status":"UNKNOWN","sponsor":"Santa Casa de Misericordia de Santos","startDate":"2009-03","conditions":"Pain","enrollment":40},{"nctId":"NCT00595543","phase":"PHASE4","title":"Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%","status":"COMPLETED","sponsor":"Bp Consulting, Inc","startDate":"2008-01","conditions":"Acute Pseudophakic Cystoid Macular Edema","enrollment":166},{"nctId":"NCT00469690","phase":"PHASE4","title":"Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects","status":"COMPLETED","sponsor":"Innovative Medical","startDate":"2007-05","conditions":"Cataract","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ketorolac eye drops","genericName":"ketorolac eye drops","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ketorolac eye drops work by reducing inflammation and pain in the eye by inhibiting prostaglandin synthesis. Used for Ocular pain and inflammation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}